Vahid Lohrasbi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vahid Lohrasbi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Neda Shirmohammadlou
Department of Microbiology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
3 shared publications- Abed Zahedi Bialvaei
Microbial Biotechnology Research Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication Amine Dalir
Department of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
1 shared publication- Faramarz Masjedian Jazi
Microbial Biotechnology Research Center Iran University of Medical Sciences Tehran Iran
1 shared publication Mahla Shahriary
Department of Microbiology, Faculty of Medicine, Tarbiat Modares University of Medical Sciences, Tehran, Iran
1 shared publication- Malihe Talebi
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 1 December 2021
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 15 (6) , 676-683
Antibiotic Susceptibility Pattern and Distribution of Virulence Factors Among Klebsiella pneumoniae Isolated from Healthy Volunteers
Background and Objective: The healthy people’s fecal flora in the community represents a large potential reservoir. Therefore, the current study aimed to detect antibiotic resistance patterns and virulence factors in Klebsiella pneumoniae isolated from healthy volunteers’ feces. Materials and Methods: Three hundred and fifty stool specimens were collected from sales rep healthy individuals ...
- 1 December 2021
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 15 (6) , 676-683
Open AccessAntibiotic Susceptibility Pattern and Distribution of Virulence Factors Among Klebsiella pneumoniae Isolated from Healthy Volunteers
Background and Objective: The healthy people’s fecal flora in the community represents a large potential reservoir. Therefore, the current study aimed to detect antibiotic resistance patterns and virulence factors in Klebsiella pneumoniae isolated from healthy volunteers’ feces. Materials and Methods: Three hundred and fifty stool specimens were collected from sales rep healthy individuals ...
- Open Access
- 4 May 2020
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 41 (12) , 1479-1482
A glance at the prevalence of coronavirus disease 19 (COVID-19) in Iran: Strengths and weaknesses
- 4 May 2020
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 41 (12) , 1479-1482
Open AccessA glance at the prevalence of coronavirus disease 19 (COVID-19) in Iran: Strengths and weaknesses
- Open Access
- 23 January 2020
- Published by Springer Nature in VirusDisease
- Vol. 31 (1) , 10-12
Brief outcome of five decades of battle with infectious diseases in Iran
According to WHO health profile, Iran has better situation in controlling some infection disease like leprosy, dengue fever, tularemia and hepatitis B than United States, even though Iran is in a more dangerous area than the USA. Achieving optimum control for infectious disease in the Middle East requires huge financial costs, equipment and a great time. Some of Iran’s actions to control infectious diseases include: special attention of the Iran government to the health issue, training and developing human resources, membership and close cooperation with international organizations like WHO, detecting and monitoring emerging diseases before their arrival and distribution in Iran, expanding and updating national immunization and vaccination program since 1992, national project implementation titled “Health system development plan”, supplying and manufacturing most of drugs required in Iran by the Iranian companies as a strategic planning, great coordination between different departments of the MOHME and other relevant institutions to Iran Army and Ministry of Intelligence to prevent the emergence of bioterrorism, and etc. We believe that Iran has obtained an acceptable score in the control of infectious diseases; but it still has very big challenges to reach the ideal level.
- 23 January 2020
- Published by Springer Nature in VirusDisease
- Vol. 31 (1) , 10-12
Open AccessBrief outcome of five decades of battle with infectious diseases in Iran
According to WHO health profile, Iran has better situation in controlling some infection disease like leprosy, dengue fever, tularemia and hepatitis B than United States, even though Iran is in a more dangerous area than the USA. Achieving optimum control for infectious disease in the Middle East requires huge financial costs, equipment and a great time. Some of Iran’s actions to control infectious diseases include: special attention of the Iran government to the health issue, training and developing human resources, membership and close cooperation with international organizations like WHO, detecting and monitoring emerging diseases before their arrival and distribution in Iran, expanding and updating national immunization and vaccination program since 1992, national project implementation titled “Health system development plan”, supplying and manufacturing most of drugs required in Iran by the Iranian companies as a strategic planning, great coordination between different departments of the MOHME and other relevant institutions to Iran Army and Ministry of Intelligence to prevent the emergence of bioterrorism, and etc. We believe that Iran has obtained an acceptable score in the control of infectious diseases; but it still has very big challenges to reach the ideal level.
- 1 April 2019
- Published by Elsevier in Journal of Hospital Infection
- Vol. 101 (4) , 480-481
A tsunami of drug resistance in Iran's hospitals, is it true?
- 1 April 2019
- Published by Elsevier in Journal of Hospital Infection
- Vol. 101 (4) , 480-481
A tsunami of drug resistance in Iran's hospitals, is it true?